Caffeine Completed Phase N/A Trials for BMI >30 kg/m2 Prevention

IndicationsStatusPurposePhase
CompletedPreventionNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01710722The Effect of Leptin A-200, Caffeine/Ephedrine and Their Combination Upon Weight Loss and Body Composition in Man